{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:09:24Z","timestamp":1789729764359,"version":"4.0.1"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["17JR5RA272"],"award-info":[{"award-number":["17JR5RA272"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["22JR5RA923"],"award-info":[{"award-number":["22JR5RA923"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016321","name":"Lanzhou University First Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","award":["Ldyyyn2021\\u201330"],"award-info":[{"award-number":["Ldyyyn2021\\u201330"]}],"id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","award":["Ldyyyn2021\\u2013120"],"award-info":[{"award-number":["Ldyyyn2021\\u2013120"]}],"id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cellsig.2025.112213","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:35:48Z","timestamp":1762360548000},"page":"112213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cancer-associated fibroblasts: The \"Achilles' Heel\" in thyroid tumor progression and therapy"],"prefix":"10.1016","volume":"138","author":[{"given":"Xiaoxiao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengtong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-xun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cellsig.2025.112213_bb0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/jama.2024.5725","article-title":"What is thyroid Cancer?","volume":"332","author":"Voelker","year":"2024","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4143\/crt.2015.310","article-title":"Risk factors for thyroid Cancer: a hospital-based case-control study in Korean adults","volume":"49","author":"Myung","year":"2017","journal-title":"Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0015","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid Cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.cellsig.2025.112213_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101013","article-title":"Radioiodine-refractory differentiated thyroid cancer: molecular mechanisms and therapeutic strategies for radioiodine resistance","volume":"72","author":"Shen","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.cellsig.2025.112213_bb0030","first-page":"4","article-title":"The tumor microenvironment: signal transduction","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mdr2.70007","article-title":"Breaking boundaries: chronic diseases and the Frontiers of immune microenvironments","volume":"1","author":"Li","year":"2025","journal-title":"Med Research."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112213_bb0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","article-title":"Cancer associated fibroblasts in cancer development and therapy","volume":"18","author":"Jia","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"25","key":"10.1016\/j.cellsig.2025.112213_bb0050","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1038\/s41388-019-0765-y","article-title":"Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment","volume":"38","author":"Bu","year":"2019","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.cellsig.2025.112213_bb0055","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169653","article-title":"Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics","volume":"133","author":"Lu","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2025.112213_bb0060","doi-asserted-by":"crossref","first-page":"1019072","DOI":"10.3389\/fendo.2022.1019072","article-title":"Integrated analysis of fibroblasts molecular features in papillary thyroid cancer combining single-cell and bulk RNA sequencing technology","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/diseases11010009","article-title":"Transcriptome analysis revealed potential neuro-immune interaction in papillary thyroid carcinoma tissues","volume":"11","author":"Hu","year":"2023","journal-title":"Diseases"},{"issue":"7","key":"10.1016\/j.cellsig.2025.112213_bb0070","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/0008-5472.CAN-15-2351","article-title":"Fibroblast-mediated collagen remodeling within the tumor microenvironment facilitates progression of thyroid cancers driven by BrafV600E and Pten loss","volume":"76","author":"Jolly","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0075","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1038\/s41598-019-44361-6","article-title":"Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression","volume":"9","author":"Fozzatti","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2025.112213_bb0080","doi-asserted-by":"crossref","first-page":"41416","DOI":"10.1038\/srep41416","article-title":"Extracellular superoxide dismutase expression in papillary thyroid Cancer mesenchymal stem\/stromal cells modulates Cancer cell growth and migration","volume":"7","author":"Parascandolo","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0085","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1007\/s13277-015-4684-4","article-title":"Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma","volume":"37","author":"Sun","year":"2016","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0090","doi-asserted-by":"crossref","first-page":"20977","DOI":"10.1038\/s41598-024-72020-y","article-title":"New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma","volume":"14","author":"Xia","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112213_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151254","article-title":"Extracellular vesicles from thyroid cancer harbor a functional machinery involved in extracellular matrix remodeling","volume":"101","author":"Bravo-Miana","year":"2022","journal-title":"Eur. J. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1186\/s12885-024-12459-4","article-title":"Pathomics and single-cell analysis of papillary thyroid carcinoma reveal the pro-metastatic influence of cancer-associated fibroblasts","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13592","article-title":"Single-cell RNA sequencing to explore cancer-associated fibroblasts heterogeneity: \u201csingle\u201d vision for \u201cheterogeneous\u201d environment","volume":"57","author":"Zhang","year":"2024","journal-title":"Cell Prolif."},{"issue":"39","key":"10.1016\/j.cellsig.2025.112213_bb0115","article-title":"Single-Cell RNA sequencing reveals the heterogeneity in differentiation trajectory and tumor microenvironment leading to more aggressive phenotypes of papillary thyroid cancer in children and young adult patients","volume":"12","author":"Guo","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40364-024-00622-9","article-title":"Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing","volume":"12","author":"Lyu","year":"2024","journal-title":"Biomark. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112213_bb0125","article-title":"A spatially resolved transcriptome landscape during thyroid cancer progression","volume":"6","author":"Liao","year":"2025","journal-title":"Cell Rep Med."},{"issue":"30","key":"10.1016\/j.cellsig.2025.112213_bb0130","article-title":"PROS1-MERTK Axis drives tumor microenvironment crosstalk and progression in papillary thyroid microcarcinoma","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci (Weinh)."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112213_bb0135","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112213_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009494","article-title":"Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures","volume":"12","author":"Kabiljo","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.cellsig.2025.112213_bb0145","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.7150\/thno.94207","article-title":"Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling","volume":"14","author":"Jin","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2025.112213_bb0150","article-title":"Fibroblast atlas: shared and specific cell types across tissues","volume":"11(14):eado0173","author":"Liu","year":"2025","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112213_bb0155","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","article-title":"Fibroblasts in cancer: Unity in heterogeneity","volume":"186","author":"Chhabra","year":"2023","journal-title":"Cell"},{"issue":"27","key":"10.1016\/j.cellsig.2025.112213_bb0160","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1073\/pnas.1600363113","article-title":"Tumor-associated fibroblasts predominantly come from local and not circulating precursors","volume":"113","author":"Arina","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.cellsig.2025.112213_bb0165","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1158\/0008-5472.CAN-13-0530","article-title":"Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer","volume":"73","author":"Bochet","year":"2013","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112213_bb0170","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ncb2610","article-title":"Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature","volume":"14","author":"Rinkevich","year":"2012","journal-title":"Nat. Cell Biol."},{"issue":"38","key":"10.1016\/j.cellsig.2025.112213_bb0175","doi-asserted-by":"crossref","first-page":"E5618","DOI":"10.1073\/pnas.1608384113","article-title":"Pericyte-fibroblast transition promotes tumor growth and metastasis","volume":"113","author":"Hosaka","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.cellsig.2025.112213_bb0180","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","article-title":"Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts","volume":"67","author":"Zeisberg","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112213_bb0185","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/OTT.S294725","article-title":"Cancer-associated fibroblasts positively correlate with dedifferentiation and aggressiveness of thyroid Cancer","volume":"14","author":"Wen","year":"2021","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.cellsig.2025.112213_bb0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.humpath.2016.12.024","article-title":"Phenotypic characterization of perivascular myoid cell neoplasms, using myosin 1B, a newly identified human pericyte marker","volume":"62","author":"Meguro","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.cellsig.2025.112213_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109075","article-title":"Expression of fibroblast activation protein-\u03b1 in human deep vein thrombosis","volume":"241","author":"Oguri","year":"2024","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-021-01944-4","article-title":"Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer","volume":"40","author":"Venning","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13277-013-1053-z","article-title":"Notch and TGF-\u03b2\/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010112","article-title":"Cancer associated fibroblasts and senescent thyroid cells in the invasive front of thyroid carcinoma","volume":"12","author":"Minna","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0215","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s10238-023-00998-2","article-title":"Cancer-associated fibroblasts in papillary thyroid carcinoma","volume":"23","author":"Zhu","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112213_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1148\/radiol.212430","article-title":"(68)Ga fibroblast activation protein inhibitor PET\/CT in the detection of metastatic thyroid Cancer: comparison with (18)F-FDG PET\/CT","volume":"304","author":"Fu","year":"2022","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112213_bb0225","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1210\/jc.2004-0418","article-title":"Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma","volume":"89","author":"Zou","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112213_bb0230","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.bjc.6602856","article-title":"S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma","volume":"93","author":"Zou","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12935-022-02714-8","article-title":"Periostin: biology and function in cancer","volume":"22","author":"Dorafshan","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112213_bb0240","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","article-title":"Classifying cancer-associated fibroblasts-the good, the bad, and the target","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0245","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0250","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","article-title":"Cancer-associated fibroblast classification in single-cell and spatial proteomics data","volume":"14","author":"Cords","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0255","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/s41467-021-26343-3","article-title":"Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma","volume":"12","author":"Pu","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112213_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1516","article-title":"The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0265","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.cellsig.2025.112213_bb0270","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1158\/0008-5472.CAN-23-3252","article-title":"Dissecting FAP+ cell diversity in pancreatic Cancer uncovers an interferon-response subtype of Cancer-associated fibroblasts with tumor-restraining properties","volume":"85","author":"Cumming","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112213_bb0275","doi-asserted-by":"crossref","first-page":"1372432","DOI":"10.3389\/fimmu.2024.1372432","article-title":"A pan-cancer single-cell transcriptional analysis of antigen-presenting cancer-associated fibroblasts in the tumor microenvironment","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0280","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12943-022-01658-x","article-title":"CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment","volume":"21","author":"Pan","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2025.112213_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110601","article-title":"Cancer-associated fibroblasts: just on the opposite side of antitumour immunity?","volume":"122","author":"Guo","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112213_bb0290","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","article-title":"Activated fibroblasts in cancer: perspectives and challenges","volume":"41","author":"Caligiuri","year":"2023","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.cellsig.2025.112213_bb0295","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1111\/febs.15776","article-title":"A guide to the composition and functions of the extracellular matrix","volume":"288","author":"Karamanos","year":"2021","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112213_bb0300","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41580-024-00767-3","article-title":"Mechanisms of assembly and remodelling of the extracellular matrix","volume":"25","author":"Naba","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112213_bb0305","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2025.05.003","article-title":"The extracellular matrix in cancer: from understanding to targeting","volume":"11","author":"Chitty","year":"2025","journal-title":"Trends Cancer."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0310","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2559.2011.03791.x","article-title":"Desmoplastic stromal reaction in papillary thyroid microcarcinoma","volume":"58","author":"Koperek","year":"2011","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0315","first-page":"59","article-title":"Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma","volume":"31","author":"Koperek","year":"2007","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112213_bb0325","first-page":"3368","article-title":"Reduced expression of stromal-derived factor 1 in autonomous thyroid adenomas and its regulation in thyroid-derived cells","volume":"86","author":"Aust","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112213_bb0330","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0335","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3892\/ijo.2016.3485","article-title":"Expression and function of CXCL12\/CXCR4\/CXCR7 in thyroid cancer","volume":"48","author":"Zhu","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0340","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1530\/EC-20-0113","article-title":"Thyroid tumor cells-fibroblasts crosstalk: role of extracellular vesicles","volume":"9","author":"Bravo-Miana","year":"2020","journal-title":"Endocr. Connect."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112213_bb0345","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/ijc.23925","article-title":"Stromal myofibroblasts are drivers of invasive cancer growth","volume":"123","author":"De Wever","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112213_bb0350","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH643>3.0.CO;2-W","article-title":"Fibrosis in undifferentiated (anaplastic) thyroid carcinomas: evidence for a dual action of tumour cells in collagen type I synthesis","volume":"191","author":"Dahlman","year":"2000","journal-title":"J. Pathol."},{"issue":"5957","key":"10.1016\/j.cellsig.2025.112213_bb0355","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.1176009","article-title":"The extracellular matrix: not just pretty fibrils","volume":"326","author":"Hynes","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0360","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12392","article-title":"Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives","volume":"43","author":"Fang","year":"2023","journal-title":"Cancer Commun (Lond)."},{"key":"10.1016\/j.cellsig.2025.112213_bb0370","doi-asserted-by":"crossref","DOI":"10.1177\/09603271221111333","article-title":"Ursolic acid inhibits proliferation, migration and invasion of human papillary thyroid carcinoma cells via CXCL12\/CXCR4\/CXCR7 axis through cancer-associated fibroblasts","volume":"41","author":"Cao","year":"2022","journal-title":"Hum. Exp. Toxicol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112213_bb0375","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jss.2014.04.016","article-title":"The involvement of CXCR7 in modulating the progression of papillary thyroid carcinoma","volume":"191","author":"Liu","year":"2014","journal-title":"J. Surg. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0380","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0385","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112213_bb0390","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf030","article-title":"Tenascin-C potentiates Wnt signaling in thyroid Cancer","volume":"166","author":"Hartmann","year":"2025","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0395","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1186\/s12935-021-02344-6","article-title":"E-cadherin on epithelial-mesenchymal transition in thyroid cancer","volume":"21","author":"Zhu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cellsig.2025.112213_bb0400","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","article-title":"Update on epithelial-mesenchymal plasticity in Cancer progression","volume":"19","author":"Fontana","year":"2024","journal-title":"Annu. Rev. Pathol."},{"issue":"19","key":"10.1016\/j.cellsig.2025.112213_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193181","article-title":"MEG3 expression indicates lymph node metastasis and presence of Cancer-associated fibroblasts in papillary thyroid Cancer","volume":"11","author":"Dadafarin","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0410","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12957-020-01958-w","article-title":"Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer","volume":"18","author":"Li","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.cellsig.2025.112213_bb0415","doi-asserted-by":"crossref","first-page":"1076640","DOI":"10.3389\/fendo.2023.1076640","article-title":"STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma","volume":"14","author":"He","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.cellsig.2025.112213_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217076","article-title":"Metabolic reprogramming in tumor immune microenvironment: impact on immune cell function and therapeutic implications","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0425","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","article-title":"Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112213_bb0430","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/lary.25799","article-title":"Multicompartment metabolism in papillary thyroid cancer","volume":"126","author":"Curry","year":"2016","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0435","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","article-title":"Targeting stromal glutamine Synthetase in tumors disrupts tumor microenvironment-regulated Cancer cell growth","volume":"24","author":"Yang","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2025.112213_bb0440","first-page":"1170","article-title":"A glance at the actual role of glutamine metabolism in thyroid tumorigenesis","volume":"20","author":"Abooshahab","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.cellsig.2025.112213_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101055","article-title":"Lipids in the tumor microenvironment: from cancer progression to treatment","volume":"80","author":"Corn","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.cellsig.2025.112213_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155905","article-title":"Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression","volume":"155","author":"Yang","year":"2024","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discovery."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0460","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer immune evasion, immunoediting and intratumour heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0465","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s43556-024-00233-8","article-title":"Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets","volume":"5","author":"Lv","year":"2024","journal-title":"Mol Biomed."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112213_bb0470","article-title":"Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction","volume":"3","author":"Xu","year":"2023","journal-title":"Cell Genom."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0475","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112213_bb0480","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41418-023-01217-x","article-title":"METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer","volume":"30","author":"Ning","year":"2023","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41419-020-03294-z","article-title":"A new risk factor indicator for papillary thyroid cancer based on immune infiltration","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0490","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008983","article-title":"Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0495","doi-asserted-by":"crossref","first-page":"2458324","DOI":"10.1080\/08916934.2025.2458324","article-title":"CAFs-released exosomal CREB1 promotes cell progression and immune evasion in thyroid cancer via the positive regulation of CCL20","volume":"58","author":"Zheng","year":"2025","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0500","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-023-01731-z","article-title":"Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Pei","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2025.112213_bb0505","doi-asserted-by":"crossref","first-page":"1643421","DOI":"10.3389\/fimmu.2025.1643421","article-title":"Advances in PD-1\/PD-L1 pathway inhibitors in the treatment of thyroid cancer: mechanisms and clinical therapeutic perspectives","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.112213_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217475","article-title":"FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity","volume":"612","author":"Wei","year":"2025","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112213_bb0515","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1177\/10507256251372644","article-title":"Targeting B7-H3 in Cancer-associated fibroblasts using Nanosystems suppresses anaplastic thyroid carcinoma progression","volume":"35","author":"Chen","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.cellsig.2025.112213_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101273","article-title":"The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors","volume":"82","author":"Zhang","year":"2025","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0525","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of Cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cellsig.2025.112213_bb0530","article-title":"Correction: MUC1 Oncoprotein promotes refractoriness to chemotherapy in thyroid Cancer cells","volume":"78(21):6344","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112213_bb0535","doi-asserted-by":"crossref","first-page":"1412337","DOI":"10.3389\/fcell.2024.1412337","article-title":"Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression","volume":"12","author":"Chen","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065471","article-title":"Targeting tumor microenvironment Akt signaling represents a potential therapeutic strategy for aggressive thyroid Cancer","volume":"24","author":"Mirshahidi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112213_bb0545","first-page":"307","article-title":"Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells","volume":"37","author":"Zheng","year":"2010","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112213_bb0550","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archotol.133.10.1022","article-title":"Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines","volume":"133","author":"Lopez","year":"2007","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.cellsig.2025.112213_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217917","article-title":"Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer","volume":"631","author":"He","year":"2025","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0560","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2018.08.006","article-title":"Increased lactate secretion by Cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies","volume":"28","author":"Apicella","year":"2018","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112213_bb0565","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.trecan.2022.03.001","article-title":"Targeting CAFs to overcome anticancer therapeutic resistance","volume":"8","author":"Saw","year":"2022","journal-title":"Trends Cancer."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112213_bb0570","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009281","article-title":"NAD(+) metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer","volume":"12","author":"Yang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0575","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cpan.2024.12.002","article-title":"Advances in drug discovery based on network pharmacology and omics technology","volume":"21","author":"Liu","year":"2024","journal-title":"Curr. Pharm. Anal."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0580","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12964-023-01125-0","article-title":"What is new in cancer-associated fibroblast biomarkers?","volume":"21","author":"Zhao","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.cellsig.2025.112213_bb0585","doi-asserted-by":"crossref","first-page":"1536063","DOI":"10.3389\/fonc.2025.1536063","article-title":"Transcriptome sequencing revealed that lymph node metastasis of papillary thyroid microcarcinoma is associated with high THBS4 expression and PDGFRA+ cancer-associated fibroblasts","volume":"15","author":"Hu","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0590","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/mdr2.70004","article-title":"Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid Cancer molecular subtypes","volume":"1","author":"Zhang","year":"2025","journal-title":"Med Research."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0595","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13046-025-03387-7","article-title":"Cancer-associated fibroblasts as a potential novel liquid biopsy marker in cancer patients","volume":"44","author":"Weber","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0600","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13046-024-03262-x","article-title":"Identification and characterization of tumor and stromal derived liquid biopsy analytes in pancreatic ductal adenocarcinoma","volume":"44","author":"G\u00f6tze","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.cellsig.2025.112213_bb0605","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1158\/0008-5472.CAN-15-1633","article-title":"Identification of Cancer-associated fibroblasts in circulating blood from patients with metastatic breast Cancer","volume":"75","author":"Ao","year":"2015","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112213_bb0610","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pros.22553","article-title":"Circulating fibroblast-like cells in men with metastatic prostate cancer","volume":"73","author":"Jones","year":"2013","journal-title":"Prostate"},{"issue":"11","key":"10.1016\/j.cellsig.2025.112213_bb0615","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000005348","article-title":"Recent clinical implications of FAPI: imaging and therapy","volume":"49","author":"Kiani","year":"2024","journal-title":"Clin. Nucl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0620","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00259-023-06404-z","article-title":"Head-to-head comparison of [(68)Ga]Ga-DOTA.SA.FAPi with [(18)F]F-FDG PET\/CT in radioiodine-resistant follicular-cell derived thyroid cancers","volume":"51","author":"Ballal","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"23","key":"10.1016\/j.cellsig.2025.112213_bb0625","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1158\/1078-0432.CCR-23-1983","article-title":"Fibroblast activation protein-targeted Radioligand therapy with 177Lu-EB-FAPI for metastatic radioiodine-refractory thyroid Cancer: first-in-human, Dose-Escalation Study","volume":"29","author":"Fu","year":"2023","journal-title":"Clin Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0630","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12032-024-02355-z","article-title":"CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-\u03b2 pathway","volume":"41","author":"Ma","year":"2024","journal-title":"Med. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0635","first-page":"2196","article-title":"Targeting TGF-\u03b21 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2\/9 signalling","volume":"8","author":"Zhang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cellsig.2025.112213_bb0640","article-title":"Circular RNA 14580 promotes papillary thyroid cancer progression by interacting with CTSW\/fibrosis singling pathway","volume":"286","author":"Wu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112213_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097872","article-title":"Modulation of EZH2 activity induces an Antitumoral effect and cell Redifferentiation in anaplastic thyroid Cancer","volume":"24","author":"de Mello","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112213_bb0650","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10529-013-1173-y","article-title":"Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression","volume":"35","author":"Zhang","year":"2013","journal-title":"Biotechnol. Lett."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112213_bb0655","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/0008-5472.CAN-14-2304","article-title":"miR30a inhibits LOX expression and anaplastic thyroid cancer progression","volume":"75","author":"Boufraqech","year":"2015","journal-title":"Cancer Res."},{"issue":"Pt 2","key":"10.1016\/j.cellsig.2025.112213_bb0660","article-title":"Decoding tumors from fibroblast activation protein: a review of the latest diagnostic and therapeutic prospects","volume":"318","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112213_bb0665","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00259-023-06144-0","article-title":"Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies","volume":"50","author":"Priv\u00e9","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112213_bb0670","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","article-title":"Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0675","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/1078-0432.CCR-17-2033","article-title":"Alteration of the tumor stroma using a consensus DNA vaccine targeting fibroblast activation protein (FAP) synergizes with antitumor vaccine therapy in mice","volume":"24","author":"Duperret","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112213_bb0680","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.apsb.2025.02.040","article-title":"Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis","volume":"15","author":"Zou","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112213_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188945","article-title":"Reprogramming of cancer-associated fibroblasts combined with immune checkpoint inhibitors: a potential therapeutic strategy for cancers","volume":"1878","author":"Li","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112213_bb0690","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2025.112213_bb0695","doi-asserted-by":"crossref","first-page":"1221532","DOI":"10.3389\/fimmu.2023.1221532","article-title":"Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta","volume":"14","author":"O\u2019Connor","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.112213_bb0700","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429310703240823045808","article-title":"Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation","volume":"17","author":"Sensi","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"424","key":"10.1016\/j.cellsig.2025.112213_bb0705","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5488","article-title":"Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-\u03b2","volume":"10","author":"Lan","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112213_bb0710","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 Axis in Cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0715","first-page":"685","article-title":"Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid","volume":"15","author":"Shao","year":"2020","journal-title":"Asian J Pharm Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0720","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","article-title":"Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1","volume":"42","author":"Zhang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0725","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1078-0432.CCR-19-1351","article-title":"Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti-PD-1 resistance in head and neck Cancer","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0730","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2025.112213_bb0735","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1515\/biol-2019-0031","article-title":"Predictive significance of serum MMP-9 in papillary thyroid carcinoma","volume":"14","author":"Xu","year":"2019","journal-title":"Open Life Sci."},{"key":"10.1016\/j.cellsig.2025.112213_bb0740","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2017.01.034","article-title":"Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression","volume":"259","author":"Isaacson","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0745","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1874467215666220324114624","article-title":"Immunomodulatory therapeutic effects of curcumin on M1\/M2 macrophage polarization in inflammatory diseases","volume":"16","author":"Abdollahi","year":"2023","journal-title":"Curr. Mol. Pharmacol."},{"issue":"21","key":"10.1016\/j.cellsig.2025.112213_bb0750","article-title":"Combination therapy of lox inhibitor and stimuli-responsive drug for Mechanochemically synergistic breast Cancer treatment","volume":"12","author":"Zhu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0755","doi-asserted-by":"crossref","first-page":"1836713","DOI":"10.1080\/19420862.2020.1836713","article-title":"Novel human monoclonal antibodies specific to the alternatively spliced domain D of tenascin C efficiently target tumors in vivo","volume":"12","author":"Nadal","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.cellsig.2025.112213_bb0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2024.04.002","article-title":"Tenascin-C targeting strategies in cancer","volume":"130","author":"Dhaouadi","year":"2024","journal-title":"Matrix Biol."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112213_bb0765","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112213_bb0770","first-page":"793","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.cellsig.2025.112213_bb0775","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.semcancer.2022.04.008","article-title":"Fibroblast heterogeneity in solid tumors: from single cell analysis to whole-body imaging","volume":"86","author":"Peltier","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0780","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.1038\/s41598-019-45842-4","article-title":"An optimised tissue disaggregation and data processing pipeline for characterising fibroblast phenotypes using single-cell RNA sequencing","volume":"9","author":"Waise","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112213_bb0785","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcmgh.2023.02.014","article-title":"Mimicking tumor cell heterogeneity of colorectal Cancer in a patient-derived organoid-fibroblast model","volume":"15","author":"Atanasova","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112213_bb0790","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13046-023-02926-4","article-title":"Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer","volume":"42","author":"Bhattacharya","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112213_bb0795","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2147\/IJN.S447350","article-title":"The application of nanoparticles targeting Cancer-associated fibroblasts","volume":"19","author":"Huang","year":"2024","journal-title":"Int. J. Nanomedicine"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500628X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500628X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T21:42:16Z","timestamp":1766094136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682500628X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":159,"alternative-id":["S089865682500628X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112213","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated fibroblasts: The \"Achilles' Heel\" in thyroid tumor progression and therapy","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112213"}}